Home

INVESTMENT PHILOSOPHY & STRATEGY

Altamont leverages its network and internal expertise to analyze data to identify high growth opportunities that generate outperforming returns. After making an investment, Altamont assists its portfolio companies in pursuing their market growth opportunities and product research and development by working closely with founders and management to build value. Altamont’s portfolio spans a wide range of therapeutic areas and products. We leverage our network of renowned PhDs, MD Researchers, and Practitioners to support optimization of clinical development programs of our portfolio companies.

Altamont is a biotech investment firm focusing on investments in undervalued small to mid-cap, publicly traded biotech companies, incubating startup companies by licensing promising technologies from world-renowned research institutes and universities, as well as partnering with large pharma companies around the world. Altamont’s philosophy is to invest long-term in the vision of the entrepreneurs and scientists striving to cure life threatening diseases and reduce the effects of chronic disease.